Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

Bridget F. Collins, Ganesh Raghu
European Respiratory Review 2019 28: 190022; DOI: 10.1183/16000617.0022-2019
Bridget F. Collins
Center for Interstitial Lung Diseases, University of Washington Medical Center, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ganesh Raghu
Center for Interstitial Lung Diseases, University of Washington Medical Center, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: graghu@uw.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 28 no. 153
DOI 
https://doi.org/10.1183/16000617.0022-2019
PubMed 
31578210

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received February 2, 2019
  • Accepted May 24, 2019
  • Published online October 1, 2019.

Copyright & Usage 
Copyright ©ERS 2019. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Bridget F. Collins and
  2. Ganesh Raghu⇑
  1. Center for Interstitial Lung Diseases, University of Washington Medical Center, Seattle, WA, USA
  1. Ganesh Raghu, Center for Interstitial Lung Disease, University of Washington 1959, NE Pacific Ave, Seattle, WA 98195, USA. E-mail: graghu{at}uw.edu
View Full Text

Article usage

Article usage: October 2019 to December 2022

AbstractFullPdf
Oct 20192315291117
Nov 201917810473
Dec 201916593223
Jan 20206723251
Feb 202013902297
Mar 20208630190
Apr 202014537140
May 202016580292
Jun 202014595254
Jul 202035552181
Aug 202018598190
Sep 202029607244
Oct 202029768256
Nov 202028687262
Dec 202037728204
Jan 202126690194
Feb 202125732168
Mar 202129691251
Apr 202117571165
May 202122627141
Jun 202119583155
Jul 202127443116
Aug 202117471135
Sep 202128482142
Oct 202133444158
Nov 202129437174
Dec 202125355203
Jan 202231337193
Feb 202218307204
Mar 202238347209
Apr 202230240118
May 20222025487
Jun 20222718547
Jul 20221818754
Aug 20222318355
Sep 20222725584
Oct 20221926267
Nov 20222419996
Dec 20222014160

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 28 Issue 153 Table of Contents
European Respiratory Review: 28 (153)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
Bridget F. Collins, Ganesh Raghu
European Respiratory Review Sep 2019, 28 (153) 190022; DOI: 10.1183/16000617.0022-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
Bridget F. Collins, Ganesh Raghu
European Respiratory Review Sep 2019, 28 (153) 190022; DOI: 10.1183/16000617.0022-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Antifibrotic medications
    • Rationale for antifibrotic medications in non-IPF-PF
    • Understanding end-points in clinical trials for non-IPF-PF
    • Currently available reports and ongoing clinical trials of antifibrotic medications for non-IPF-PF
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society